Gentian Forms Alliance with Atlantic Biologicals Diagnostics

Atlantic Biologicals Diagnostics and Gentian AS announce an alliance intended to bring Gentian-labeled product, Cystatin-C Immunoassay, to the medical community for use in the diagnosis and treatment of renal diseases.   

Miami-based Atlantic Biologicals Diagnostics is a leading supplier of diagnostics to the clinical and research laboratory in the United States and Puerto Rico. Gentian AS is a major innovator in the development of world-class diagnostic products, headquartered in Norway.  

Atlantic Biologicals Diagnostics (ABD) is a subsidiary of Atlantic Biologicals Corp. (Miami, Florida), a major distributor of pharmaceuticals and unit dose products.  

“The addition of Cystatin-C Immunoassay of Gentian to the diagnostic portfolio of ABD is a major step in enriching the number of assays we can offer to diagnose and manage disorders of the renal system,” said Atlantic Biologicals President Karen L. Moody.

For further information contact:

Erik Lahti

(866) 921-3901

Email: \n This email address is being protected from spam bots, you need Javascript enabled to view it This email address is being protected from spam bots, you need Javascript enabled to view it